Views: 1
Nasdaq-traded marijuana company Bright Green Corp. is once again under scrutiny and questioning, this time for its bold plan to raise $500 million through a federal investment program aimed at immigrant investors. The company announced in a February press release that it would use funds generated by the EB-5 Immigrant Investor Program to build its "world-class manufacturing and pharmaceutical production facility" in the small town of Grants, New Mexico. Florida-based Bright Green also plans to use the money to fund research and development as well as federal drug development clinical trials. However, experts familiar with the EB-5 Immigrant Investor Program are questioning the company, noting that: the EB-5 program is most often used for supplemental capital raising, not as a primary source of funding; the program is typically used to fund real estate projects, and no marijuana-related projects appear to be funded; the U.S. Citizenship and Immigration Services (USCIS) administers the EB-5 program, and the agency is part of the federal Department of Homeland Security (DHS), which is considered anti-marijuana because marijuana is a Schedule 1 drug at the federal level.
Information source: new.qq.com/omn/author/8713560
Thump Agri and Horti Tech(Shanghai) Co., Ltd.
No. 806-808, Building 3, Forte Pujiang Center, Lane 1505, Lianhang Road, Pujiang Town, Minhang District, Shanghai, China
0086-15372315218
henry@dehuangroup.com
henry
2853528822